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Abstract Despite the increasing number of solved crystal
structures of allergens, the key question why some proteins
are allergenic and the vast majority is not remains unan-
swered. The situation is not different for fungal allergens
which cover a wide variety of proteins with different chemical
properties and biological functions. They cover enzymes, cell
wall, secreted, and intracellular proteins which, except cross-
reactive allergens, does not show any evidence for structural
similarities at least at the three-dimensional level. However,
from a diagnostic point of view, pure allergens biotechnolog-
ically produced by recombinant technology can provide us, in
contrast to fungal extracts which are hardly producible as
standardized reagents, with highly pure perfectly standardized
diagnostic reagents.
Keywords Fungi . Allergy . Allergens . Structures
The kingdom of fungi and fungal allergens
Among the over 100,000 fungal species reported [1], only a
few hundred have been described as opportunistic pathogens
[1] causing human illness through three specific mechanisms:
direct infection of the host, elicitation of deregulated immune
responses, and toxic effects due to secondary metabolites [2,
3]. Among these, about 80 mold genera have been shown to
induce type I allergic reactions in atopic individuals [4]. The
most important allergenic fungi belong to the genera
Alternaria, Aspergillus, andCladosporium [5], whereas mem-
bers of the generaCandida, Penicillium,Clavularia, and other
genus seem to be, with the exception of the genusMalassezia
in patients suffering from atopic dermatitis [6, 7], less impor-
tant as allergenic sources [8]. The host environment naturally
restricts the number of fungi capable of inducing invasive
fungi because only organisms surviving at 37 °C can grow
and propagate into the host tissues. This might be different in
the case of IgE sensitization caused by secreted allergens,
fungal spores, and mycelium fragments which can be pro-
duced outside of the host at any temperature allowing fungal
growth. It is interesting to note that the temperature-sensitive
Aspergillus giganteus and Aspergillus restrictus which pro-
duce the ribotoxins mitogillin and restrictocin, respectively,
later demonstrated to be practically identical to the major
Aspergillus fumigatus allergen Asp f 1 [9], have never been
reported as opportunistic fungal pathogens [10].
As pointed out in a recent review [11], although fungal
allergens have been clearly associated with an array of pul-
monary and skin diseases ranging from simple sensitization
[12], allergic asthma [13] to life-threatening conditions like
allergic bronchopulmonary aspergillosis [14], they have so far
been largely neglected in the field of molecular allergology.
The number of fungal allergens currently officially recognized
by the World Health Organization and International Union of
Immunological Societies (WHO/IUIS) Allergen Nomenclature
Sub-committee (www.allergen.org) is 84 for the genus
Ascomycota and 23 for the genus Basidiomycota. However, the
number of fungal proteins able to bind IgE described in the
literature exceeds 200 allergens [4] and is far to be complete
because the majority of the allergens described derives from the
most important fungal species involved in pulmonary or skin
diseases [15]. They are produced by the molds A. fumigatuswith
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23, Alternaria alternata with 11, Cladosporium herbarum with
eight described allergens involved in respiratory diseases [11],
and to the yeastMalassezia sympodialis involved in skin diseases
with ten described allergens [16]. Several of these allergens show
cross-reactivity with homologous proteins found in other fungal
species which has been clearly confirmed by experimental pro-
cedures and in many cases also in skin tests [17]. The most
frequent cross-reactive fungal allergens are listed in Table 1.
Solved three-dimensional structures of fungal allergens
The first crystal structure of a fungal allergen solved was that
of the ribotoxin restrictocin from A. restrictus [18] which is
basically identical to the fungal allergen rAsp f 1 [10]. The
ribotoxins disrupt the elongation factor binding and protein
synthesis by specifically cleaving one phosphodiester bond in
ribosomes resulting in apoptosis [19]. Although the mode of
action of the ribotoxins has been elucidated in detail [20], it is
unlikely that the enzymatic activity contributes to the allerge-
nicity of the protein because enzymatically inactive mutants of
Asp f 1 still retain the full allergenicity (R. Crameri, unpub-
lished results). However, Asp f 1, the major allergen of
A. fumigatus, is a highly specific marker for the IgE sensiti-
zation against the fungus even if close ortholog allergens
might occur across the fungal kingdom [21].
Crystals and crystal structures of the allergens Asp f 6 [22],
Mala s 6 [23], Mala s 13 [24], Asp f 11 [25], and Mala s 1 [26]
are presented in Fig. 1. Except Mala s 1, all belong to the class
of cross-reactive allergens which, notably, cross-react also to
the homologous human proteins manganese superoxide dis-
mutase, cyclophilin, and thioredoxin. This interesting phenom-
enon which could contribute to the perpetuation of the inflam-
matory response in chronic allergic diseases such as asthma,
Table 1 List of the most common cross-reactive fungal allergens
Biochemical function Allergen MW (kDa) Species References
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allergic bronchopulmonary aspergillosis, and atopic dermatitis
has been investigated in detail. Manganese superoxide dismut-
ase has been shown to cross-react not only with the human
homologous protein and allergens of other fungal species
[27–32] but also with the corresponding enzymes of
Escherichia coli and Drosophila melanogaster, the last one
unlikely to be a source of exposure for human beings [33].
The overall structure of Asp f 6 forms a homotetramer in the
crystal which is in agreement with the structures of manganese
superoxide dismutases from other eukaryotic organisms [22],
and therefore, it can be expected that manganese superoxide
dismutases frommany other fungi will cross-react with Asp f 6.
In terms of allergenicity and cross-reactivity, similar results
have been found for Mala s 6, the cyclophilin ofM. sympodialis
[23], and Asp f 11, the corresponding enzyme of A. fumigatus
[25]. Also in this case. the fungal allergens are fully cross-
reactive with the homologous human proteins cyclophilins A,
B, andCwhich share a high degree of sequence identity at amino
acid level [24, 34]. However, in terms of the three-dimensional
structure, marked differences can be observed. Like other
cyclophilins, Mala s 6 shows an overall structure consisting of
an eight-stranded antiparallel β-barrel and two α-helices cover-
ing the top and bottom of the barrel all showing the same
monomeric conformation [23]. In contrast, the crystal structure
of Asp f 11 reveals a three-dimensional domain swapping of a
central element [25]. This is an intriguing situation because in
general, cyclophilins are active in their monomeric form.
Dimerization, as shown by the crystal structure, obviously inac-
tivates the cis-trans isomerisation function, since both active sites
are masked by their own swapped loops. In vitro, however, the
Asp f 11 protein is clearly monomeric under physiological
conditions and also shows cis-trans isomerisation activity [34]
as expected for a functional enzyme. Therefore, dimerization of
Asp f 11 in vivo could represent a mechanism for the
downregulation of the enzymatic activity in absence of protein
degradation. In terms of allergenicity, Asp f 11 is fully cross-
reactive with Mala s 6, Asp f 27, an additional cyclophilin of
A. fumigatus showing a high degree of sequence identity with
Asp f 11, and with the human cyclophilins A, B, and C at amino
acid sequence level [23, 34].
The crystal structure of the M. sympodialis thioredoxin
(Mala s 13) shows a five-stranded β-sheet forming a hydro-
phobic core surrounded by five α-helices typical for other
thioredoxins [24]. The availability of the Mala s 13 crystal
structure allowed using molecular homology modeling to iden-
tify conserved, surface-exposed amino acids potentially in-
volved in immunoglobulin E binding and thus cross-reactivity
[35]. Mala s 13 is extensively cross-reactive with Asp f 28, Asp
f 29, and human thioredoxin. Notably, the gradual reduction of
the total solvent-accessible surface area forming potential B cell
epitopes between human thioredoxin, Asp f 28, Asp f 29, and
Mala s 13 coincides with the IgE binding potential of the
allergens [35]. The cross-reactivity between Mala s 13 and
human thioredoxin has been also investigated in detail at T cell
level [36]. Using ex vivo patient material from the skin and
blood of patients suffering from atopic dermatitis sensitized to
Mala s 13, it could be shown that Mala s 13-specific T lym-
phocytes are fully cross-reactive with human thioredoxin, irre-
spective of whether the T cell clones were derived from the
blood or skin [36]. Therefore, thioredoxin-autoreactive skin-
homing T cells might contribute through the secretion of pro-
inflammatory cytokines such as IFN-γ, IL-17, and IL-22 to the
pathogenesis of atopic eczema by perpetuating skin inflamma-
tion and chronification of atopic dermatitis [37].
A completely different situation emerged with the solution
of the crystal structure of Mala s 1 [26]; the major allergen of
M. sympodialis previously denoted Mala f 1 [38]. Mala s 1
lacks sequence similarity to any known protein, and as a
Fig. 1 Crystals and overall structures of a manganese superoxide
dismutase from Aspergillus fumigatus (Asp f 6), b cyclophilin from
Malassezia sympodialis (Mala s 6), c thioredoxin from Malassezia
sympodialis (Mala s 13), d cyclophilin from Aspergillus fumigatus (Asp
f 11), and e the major allergen Mala s 1 from Malassezia sympodialis
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consequence thereof also, the biological function of this aller-
gen is fully unknown. As BLAST homology searches failed to
reveal homology to known proteins allowing solving the
structure by molecular replacement [39], the crystal structure
of Mala s 1 was determined by single-wavelength anomalous
dispersion technique using selenomethionine-substituted
Mala s 1 protein [40]. The overall structure of Mala s 1
revealed a relatively compact cup-like β-propeller consisting
of six blades,α,β, χ, δ, ε, andΦ, arranged cyclically around a
central pore, a completely novel fold among allergens.
However, a search for structural homologous to Mala s 1
using the program DALI [41] resulted in a number of signif-
icant hints, and four of the five top hints were sialidases. In
deep analyses of the putative active side of Mala s 1, it
revealed significant differences between Mala s 1 and the
suggested homologs. Despite extensive investigations, an en-
zymatic function could assign to the protein. In terms of
allergenicity, it has been shown that IgE-mediated sensitiza-
tion toM. sympodialis allergens and also to Mala s 1 is highly
specific for patients with atopic eczema [16] indicating a close
relation between the yeast and the pathogenesis of the disease.
A further example of a unique allergen structure is Alt a 1,
the major allergen of A. alternata [42]. Alternaria is one of the
most common molds associated with allergic sensitization to
fungi, and up to 80 % of the patients sensitized to this fungus
produce IgE antibodies to themajor allergenAlt a 1. Natural Alt
a 1 is a 30-kDa dimer composed of two separate subunits which
migrates as two 16.4 and 15.3 kDa bands under reducing
conditions on SDS-PAGE gels, suggesting a disulfide bond
linking the monomers [43]. The protein belongs to the class
of highly species-specific fungal allergens, and in fact, very few
Alt a 1 homologous structures have been found among the
fungal kingdom [21]. A high-resolution X-ray crystal structure
of recombinant Alt a 1 reveals that the allergen forms a unique,
dimeric β-barrel structure [42], differing from all other struc-
tures currently reported in the Protein Data Bank [44] and
defines a new protein family of homologous proteins exclu-
sively found in molds. Although Alt a 1 has a classic, dimeric
structure, the data do not necessarily support the hypothesis that
dimerisation is an important prerequisite for allergenicity [45]
as described before for Asp f 11, the cyclophilin of A. fumigatus
which clearly binds IgE from the serum of sensitized patients in
monomeric and dimeric forms [25].
Concluding remarks
Despite the prominent importance as allergenic sources [11],
only few crystal structures of fungal allergens have been
solved. However, the limited data available allows drawing
firm conclusions. (i) As it is the case for all other allergens
[46], also fungal allergens can be broadly assigned to cross-
reactive protein families and unique species-specific
structures. Classical examples of cross-reactive (fungal) aller-
gens are phylogenetically highly conserved proteins like
thioredoxins, cyclophilins, ribosomal proteins, and other pro-
teins essential for metabolic processes of the cells. Species-
specific fungal allergens like the ribotoxins, Asp f 1, or the
major allergensMala s 1 and Alt a 1 seem to be proteins which
are not essential for the survival of the respective fungal
species as demonstrated by knockout experiments [47]. (ii)
The solved structures of Mala s 1 and Alt a 1 provide exam-
ples of unique allergen folds, indicating that the potential of an
allergen to induce a switch towards allergen-specific IgE
production is unlikely to be directly related to common struc-
tural folds. (iii) Although the determination of crystal struc-
tures of many allergens failed to deliver an explanation for the
allergenic potential of the proteins, they provided us with
perfectly standardized diagnostic reagents with, perhaps, also
a potential for the development of novel therapeutic concepts
for the treatment of IgE-mediated allergic diseases.
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